Actuate Therapeutics, Inc. (ACTU) stock
ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.01 (-2.38%)
Close on Nov 18, 2026Market cap $5.90MP/E –Yield –
Actuate Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Actuate Therapeutics's operating income for the twelve months ending Sep 30, 2026 was -$18.74M. For fiscal 2025 it was -$22.50M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.50M | – |
| FY2024 | Dec 31, 2024 | -$25.16M | – |
| FY2023 | Dec 31, 2023 | -$24.97M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$3.44M | – |
| Q2 FY2026 | Jun 30, 2026 | -$4.91M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.71M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.69M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.47M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.97M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.37M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.56M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.39M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.44M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.77M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.62M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.48M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.58M | – |
See a number that looks wrong?